VISTA-LIFE pharma
0820.402.640 · rovalta.com · 25/09/2026
VISTA-LIFE pharma
Company — Normal situation.
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOVISTA-LIFE pharma is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0820.402.640
- Legal form
- Public limited company
- Contributed capital
- 62 000,00 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 207
Financials
Source · NBB, 16 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 5 M € | – | – | – | – | ||||
| EBITDA | 1,6 M € | +18.8% | 1,4 M € | +537% | -313,2 k € | -292% | 163 k € | -86.4% | 1,2 M € |
| Operating result | 1,6 M € | +19.1% | 1,4 M € | +515% | -325,8 k € | -315% | 151,4 k € | -87.3% | 1,2 M € |
| Net result | 1,2 M € | +12.6% | 1,1 M € | +257% | -702,4 k € | -690% | 119,1 k € | -86.2% | 863,2 k € |
| Balance sheet | |||||||||
| Equity | 2,9 M € | +73.8% | 1,7 M € | +190% | 580,8 k € | -54.7% | 1,3 M € | +10.2% | 1,2 M € |
| Total assets | 3,9 M € | +79.9% | 2,2 M € | -22.2% | 2,8 M € | -20.2% | 3,5 M € | +19.2% | 2,9 M € |
| Cash | – | 1,1 M € | -16.2% | 1,3 M € | +89.5% | 711,9 k € | +329% | 165,8 k € | |
| Debts | 975,5 k € | +101% | 484,3 k € | -76.8% | 2,1 M € | -1.5% | 2,1 M € | +24.4% | 1,7 M € |
| Other | |||||||||
| Workforce | – | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | |
Board of directors
Source · NBB, accounts to 31/12/20255 active · 24 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 08/05/2026 | 20/05/2025 | 03/08/2024 | 03/08/2023 | 19/08/2022 | 23/07/2021 |
| General meeting | 24/04/2026 | 24/04/2025 | 15/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 16 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 24/04/2026 | 08/05/2026 | French | |
| Abridged model | 31/12/2024 | 24/04/2025 | 20/05/2025 | French | |
| Abridged model | 31/12/2023 | 15/06/2024 | 03/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 30/06/2023 | 03/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 30/06/2022 | 19/08/2022 | Dutch | |
| Abridged model | 31/12/2020 | 30/06/2021 | 23/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 22/06/2020 | 13/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 30/06/2019 | 28/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 30/06/2018 | 31/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 17/06/2017 | 31/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 18/06/2016 | 29/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 20/06/2015 | 27/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 21/06/2014 | 07/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 15/06/2013 | 29/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 16/06/2012 | 30/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 18/06/2011 | 12/08/2011 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20255 active · 24 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution28/11/2025RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring06/10/2025RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates18/08/2025DEMISSIONS, NOMINATIONS
- Mandates30/05/2025DEMISSIONS, NOMINATIONS
- Mandates27/01/2025SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates28/11/2024ONTSLAGEN - BENOEMINGEN
- Mandates24/05/2023ONTSLAGEN - BENOEMINGEN
- Mandates14/12/2017ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20251,2 M €↑
- 2024Annual accounts 20241,1 M €↑
- 2023Annual accounts 2023-702,4 k €↓
- 2022Annual accounts 2022119,1 k €↓
- 2021Annual accounts 2021863,2 k €↑
- 2020Annual accounts 2020601,7 k €↑
- 2018Annual accounts 2018155,4 k €↑
- 2017Annual accounts 201731,3 k €↑
- 2016Annual accounts 2016-110,5 k €↓
- 2015Annual accounts 201550,4 k €↓
- 2014Annual accounts 201464,1 k €↑
- 2013Annual accounts 2013-98 k €↑
- 2012Annual accounts 2012-215,4 k €↓
- 2011Annual accounts 2011-173,9 k €↑
- 2010Annual accounts 2010-445,6 k €